SWOT Analysis Reports & Company Profiles

Publications found: 164,030
Sort by:

General Dynamics Land Systems - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for General Dynamics Land Systems for the year 2012 based on a comprehensive assessment of...

December 2011 20 pages

General Motors Company - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for General Motors Company for the year 2012 based on a comprehensive assessment of company...

December 2011 20 pages

Gulfstream Aerospace Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Gulfstream Aerospace Corporation for the year 2012 based on a comprehensive assessment...

December 2011 20 pages

Hawker Beechcraft Corporation- Key Strategies, Plans , SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Hawker Beechcraft Corporation for the year 2012 based on a comprehensive assessment of...

December 2011 20 pages

Iveco S.p.A. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Iveco S.p.A. for the year 2012 based on a comprehensive assessment of company’s global...

December 2011 20 pages

Key Global Armoured Vehicle Manufacturers - Strategic Initiatives, Developments, SWOT, Key Trends & Outlook for 2012

US$ 995.00

The report brings to forefront & provides key insights as well as an incisive perspective through a comprehensive analysis of the Strategic Initiatives as well as Developments for these 5 key Glob...

December 2011 65 pages

Key Global Business Jet Manufacturers - Strategic Initiatives, Developments, SWOT, Key Trends & Outlook for 2012

US$ 995.00

The report brings to forefront & provides key insights as well as an incisive perspective through a comprehensive analysis of the Strategic Initiatives as well as Developments for these 6 key Glob...

December 2011 70 pages

Key Global Helicopter Manufacturers - Strategic Initiatives, Developments, SWOT, Key Trends & Outlook for 2012

US$ 995.00

The report brings to forefront & provides key insights as well as an incisive perspective through a comprehensive analysis of the Strategic Initiatives as well as Developments for these 5 key Glob...

December 2011 65 pages

Komatsu Ltd. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Komatsu Ltd. for the year 2012 based on a comprehensive assessment of company’s global...

December 2011 20 pages

L-3 Communications Holdings Inc. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for L-3 Communications Holdings Inc. for the year 2012 based on a comprehensive assessment...

December 2011 20 pages

Lockheed Martin Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Lockheed Martin Corporation for the year 2012 based on a comprehensive assessment of co...

December 2011 20 pages

MAN Truck & Bus AG - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for MAN Truck & Bus AG for the year 2012 based on a comprehensive assessment of company...

December 2011 20 pages

Navistar Defense LLC - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Navistar Defense LLC for the year 2012 based on a comprehensive assessment of company’s...

December 2011 20 pages

Navistar International Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Navistar International Corporation for the year 2012 based on a comprehensive assessmen...

December 2011 20 pages

Northrop Grumman Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Northrop Grumman Corporation for the year 2012 based on a comprehensive assessment of c...

December 2011 20 pages

Oshkosh Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Oshkosh Corporation for the year 2012 based on a comprehensive assessment of company’s...

December 2011 20 pages

PACCAR Inc. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for PACCAR Inc. for the year 2012 based on a comprehensive assessment of company’s global b...

December 2011 20 pages

PSA Group - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for PSA Group for the year 2012 based on a comprehensive assessment of company’s global bus...

December 2011 20 pages

Raytheon Company - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Raytheon Company for the year 2012 based on a comprehensive assessment of company’s glo...

December 2011 20 pages

Renault Group - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Renault Group for the year 2012 based on a comprehensive assessment of company’s global...

December 2011 20 pages

Scania AB - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Scania AB for the year 2012 based on a comprehensive assessment of company’s global bus...

December 2011 20 pages

Textron Inc. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Textron Inc. for the year 2012 based on a comprehensive assessment of company’s global...

December 2011 20 pages

Thales S.A. - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Thales S.A. for the year 2012 based on a comprehensive assessment of company’s global b...

December 2011 20 pages

The Boeing Company - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for The Boeing Company for the year 2012 based on a comprehensive assessment of company’s g...

December 2011 20 pages

Toyota Motor Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Toyota Motor Corporation for the year 2012 based on a comprehensive assessment of compa...

December 2011 20 pages

United Technologies Corporation - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for United Technologies Corporation for the year 2012 based on a comprehensive assessment o...

December 2011 20 pages

Volkswagen AG - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Volkswagen AG for the year 2012 based on a comprehensive assessment of company’s global...

December 2011 20 pages

Volvo AB - Key Strategies, Plans, SWOT, Trends & Outlook for 2012

US$ 355.00

This Strategic Report Analyzes & provides Insights into the Key Strategies, Plans & business outlook for Volvo AB for the year 2012 based on a comprehensive assessment of company’s global busi...

December 2011 20 pages

World's 7 Leading Truck-Makers - Strategic Initiatives, Developments, SWOT, Key Trends & Outlook for 2012

US$ 995.00

The report brings to forefront & provides key insights as well as an incisive perspective through a comprehensive analysis of the Strategic Initiatives as well as Developments for these 7 key Glob...

December 2011 80 pages

Emerging Chemistry and Immunodiagnostic Tests and Companies Developing New Technologies

US$ 2,720.00

The report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products. Contains 258 pages and 44 tables

December 2011 258 pages

Onyx Pharma, Market Perform - M&A Rumors Fuel Investors Interest and Stock Movement

US$ 90.00

Recent news about “possible acquisition of Onyx pharma” is not a surprise in light of the upcoming ... over Regorafenib (BAY73-4506, PhIII) with Bayer. Onyx product pipeline focuses only in oncology. We have ... released on 30th November, 2011 on Onyx pharma titled “M&A Rumors Fuel Investors Interest and Stock ...

November 2011 6 pages

AMGN - Old is Gold = Value Buy!

US$ 140.00

... philosophy to pursue “innovation” in a balanced way should keep shareholders interested in AMGN for long term. PhIII data from study ‘147 published ... more detail, please read our report released on 25th November on AMGN titled “AMGN - Old is Gold = Value Buy!”

November 2011 4 pages

Global Paint and Coatings Companies M&A, Joint Ventures, R&D Pipeline, and Strategies

US$ 10,160.00

... , factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading paints and coatings companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors. To ...

November 2011 500 pages

Albiglutide - Top line data from HARMONY 7 - Inferior on Efficacy to Victoza, but a competitive clinical profile overall

US$ 90.00

... the needed competitive edge. In top line data there is no mention about the skin related adverse events, which if albiglutide is able to avoid, it would ... . We await the detailed data which will be announced at upcoming diabetes conference (Table 2). Table 3 compares Albiglutide with other late stage GLP ...

November 2011 4 pages

AMARIN - NCE vs. “Me-Too”- 3 or 5 years of Minimum Life?

US$ 140.00

... designate AMR101 as a NCE, it will have… For more details, please read our report released on Nov. 16th, 2011 on AMRN titled “NCE vs. “Me-Too”- 3 or 5 years ...

November 2011 3 pages

ATLAS ACS 2-TIMI 51 ACS - Major bleeding will restrict potential in ACS

US$ 140.00

Robust mortality benefit demonstrated by Xarelto in ACS patients, though at the cost of higher major TIMI bleeds (but less fatal bleeds), warrants an ... concomitant Atrial Fibrillation (~ 3-10% of the ACS patients). We forecast $XX in peak sales for Xarelto in ACS and $XX across all indications (DVT treatment ...

November 2011 7 pages

ASTELLAS - FDA Accepts Mirabegron NDA - Signals Elimination of Glaucoma Concerns - Approval Should be on Time!

US$ 90.00

FDA has accepted NDA of mirabegron (first in class β3-AR agonist, overactive bladder ... over the fate of this important candidate for Astellas whose aim is to maintain its leadership in ... and reach the market on time. We are expecting, mirabegron will be targeted 30% of patients on antimuscarinic therapy who ...

November 2011 3 pages

AUROBINDO - A Washout Result

US$ 140.00

Aurobindo’s Q2 FY12 result was much below our expectations with almost complete washout on every parameter. While formulation sales, income from dossier, gross ...

November 2011 6 pages

TOWA - Performance Will Outcast New ‘Mid Term Plan’

US$ 140.00

In Towa’s MTP announcement, it has projected single digit revenue growth and assumed there will not be any ‘New Major Reform’ by Govt to enhance ... in dispensing fee and incentives to doctors will boost Towa’s revenue (as 90%+ its revenue from these two segments), 2) Towa management is taking the right decision ...

November 2011 7 pages

Ablynx NV – “Nanobodies – Still Worth a Risk”

US$ 140.00

... to the advanced anti-TNF (Ozoralizumab, ATN-103, PhIIb, RA) nanobody program to Ablynx (ABLX) has shaken investor’s confidence in the company. Outcome of the ... collaborations with major pharma companies for its technology platform. Ablynx is currently trading close to its cash value and could be a good ...

November 2011 4 pages

AstraZeneca - TC-5214 reported negative Topline Data from EU study; while outcome from other studies still awaited

US$ 90.00

... top line data of TC-5214 from European PhIII study ( ... , reported adverse events were similar to what it was observed in PhIIb trial (Constipation, Asthenia). A negative outcome ... in PhIII EU studies (Chart 1- Geography wise market size MDD, EU – 22%) comes as a blow for Targacept/AstraZeneca ...

November 2011 4 pages

BIOGEN IDEC - Data of BG-12 + Sales Growth Brighten 2012 Prospects

US$ 140.00

Biogen Idec (BIIB) is closing 2011 with a positive note and ... Copaxone (L, RRMS) share of the MS market. Moreover, PhIIb data readouts from SELECT trial of Daclizumab HYP (PhII, IL-2 alpha subunit ... read our report, released on Nov. 8, 2011 on “Biogen Idec - Data of BG-12 + Sales Growth Brighten 2012 Prospects”

November 2011 6 pages

ASTELLAS - Commercialization Terms Fade MDV-3100 Clinical Success for Astellas!

US$ 90.00

Astellas released solid interim data from AFFIRM trial on MDV-3100 ... this solid data, we find a limited bottom line impact on Astellas due to its commercialization agreement with Medivation. Under the agreement, Medivation will ... receive upto $650m milestone payment which leaves a little for Astellas’s investor.

November 2011 3 pages

Roche Group business profile (company report)

US$ 99.00

This report examines key company data such as Roche Group foundation and activities, it’s structure, actual financial results and recent important events which influenced latest company’s performance...

November 2011 43 pages

ICBC (Asia) business profile (company report)

US$ 99.00

This report examines key company data such as ICBC (Asia) foundation and activities, it’s structure, actual financial results and recent important events which influenced latest company’s performance...

November 2011 50 pages

Sun Pharma - Cardizem CD – Para IV For An Age Old Compound, Still Enjoys Limited Competition

US$ 90.00

As expected, Sun Pharma received the final approval for generic Cardizem CD (annual sales of $300m) for all the strengths, viz. 120 mg, ... the patented price. All the current generic companies including Sun pharma has settled the Para IV litigation with Valeant (erstwhile Biovail ...

October 2011 3 pages

BIOGEN IDEC - Dominating Multiple Sclerosis Market for Long Term!

US$ 90.00

... read our report released on 25th October, 2011 on BIIB titled “Dominating Multiple Sclerosis Market for Long Term!”

October 2011 4 pages

Philips India - Company Analysis

US$ 500.00

“Philips India – Company Analysis” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source and features lat...

October 2011 49 pages

Gulfstream Aerospace Corporation - Strategic Snapshot & SWOT Analysis - Q4 2011

US$ 150.00

SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...

October 2011 15 pages

Embraer S.A.- Strategic Snapshot & SWOT Analysis - Q4 2011

US$ 150.00

SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...

October 2011 15 pages

Filters

Search

Categories

7,665
6,761
4,993
4,645
4,328
4,036
3,979
3,241
3,083
2,925
2,713
2,595
2,125
2,024
2,008
1,654
1,587
1,254
1,158
1,091
982
791
789
572
494
493
304
1,542
9,254
3,983
67,744
8,589
1,186
3,442

Publishers

53,883
43,113
1,245
3
12
1
5
4
2
2
9
11,951
6
5
12,341
6
3
11,044
12
27
48
6
356
24,220
1
1,042
7
1
1,225
1,830
3
149
352
4
2
2
517
1
60

Regions

171
94
91
91
83
80
54
43
34
32
30
19
18
17
13
12
12
12
11
6
5
5
5
5
4
4
4
4
4
4
3
2
2
2
2
2
2
2
1
470
3
1
1
1
4,304
584
433
18
12
121
9
20
12
1
66
7
1
1,007
32
19
38
40
1
154
20
506
178
28,201
65
240
189
30
630
191
163
299
18
413
48
1,433
634
14
100
23
1,445
1
32
398
1
35
41
322
217
19
23
440
8
1
10
355
671
465
429
3,775
925
8,253
1,134
3
2,843
1,162
4
1
2
3,375
1,390
996
272
798
695
402
2,433
1,099
9,272
120
1,012
4,876
884
503
2
1,712
87
2
167
16
8,662
1,193
80
5,494
313
2,376
707
135
1
4
12
3
42,543
7,541

Price

—

Date

—

Pages

—

Offers